We wrote this for you
Read our 2023 Year in Review to see our accomplishments over the past year as a global leader in diabetes research, patient care, and education.
Posts tagged as
Mark Atkinson
Homepage
Welcome At the University of Florida Diabetes Institute, we are working together for a diabetes-free world.
Type 1 Diabetes Patients Retain Some Ability to Produce Insulin, UF Health Researchers Find
As an autoimmune disease, Type 1 diabetes has long been thought to result from a complete immune system killing of the insulin-producing beta cells within the pancreas. Now, University of Florida Health researchers have made a striking discovery: some of the pancreas’ ability to produce insulin may remain for decades…
Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics
UFDI Director Mark Atkinson, Ph.D. and collaborators found that GABA is rapidly absorbed and tolerated in human beings. They believe that its endocrine effects suggest potential therapeutic benefits for diabetes.
Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes
UFDI and nPOD investigators found that the presence of β-cells as well as insulitis several years after T1D diagnosis in children and young adults suggest that the chronicity of islet autoimmunity extends well into the post-diagnosis period.
Immune Depletion in Combination with Allogeneic Islets Permanently Restores Tolerance to Self-Antigens in Diabetic NOD Mice
UFDI researchers Amanda Posgai, Ph.D. and Mark Atkinson, Ph.D. and collaborators examine a new approach for preserving beta cell function in patients with recent onset T1D.
Study of GABA in Healthy Volunteers: Pharmacokinetics and Pharmacodynamics
UFDI Researcher Mark Atkinson, Ph.D. and collaborators found that that GABA is rapidly absorbed and tolerated in human beings, and its endocrine effects suggest potential therapeutic benefits for diabetes.
Beyond the brain: disrupted in schizophrenia 1 regulates pancreatic β-cell function via glycogen synthase kinase-3β
Individuals with schizophrenia and their first-degree relatives have higher rates of type 2 diabetes than the general population (18-30 vs. 1.2-6.3%), independent of body mass index and antipsychotic medication, suggesting shared genetic components may contribute to both diseases. The cause of this association remains unknown. Mutations in disrupted in schizophrenia…
Do you have extra diabetes supplies you no longer need?
UFDI Director Mark Atkinson, Ph.D. and Insulin for Life found a way to recycle unused diabetes supplies.
